Radiotherapy: Brightness and darkness in the era of immunotherapy

The introduction of immunotherapy into cancer treatment has radically changed clinical management of tumors. However, only a minority of patients (approximately 10 to 30%) exhibit long-term response to monotherapy with immunotherapy. Moreover, there are still many cancer types, including pancreatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Danyi, An, Dandan, Wan, Chao, Yang, Kunyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881489/
https://www.ncbi.nlm.nih.gov/pubmed/35219093
http://dx.doi.org/10.1016/j.tranon.2022.101366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881489/
https://www.ncbi.nlm.nih.gov/pubmed/35219093
http://dx.doi.org/10.1016/j.tranon.2022.101366

Ejemplares similares